CLINICAL_TRIALS
trial_result
· 2013-10-07
Clinical Trial Update: MEDI-557 Adult Dosing [Phase 1]
Summary
Phase 1 trial update provides adult dosing information for MEDI-557 in Respiratory Syncytial Virus. The study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus | Phase 1 | Status: COMPLETED